Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Vor Biopharma Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 55 | 1 | 61 | +7 |
| Shares | 30.7M | 91.9K | 31.2M | +555.0K (+1.8%) |
| Value | $481.2M | $1.44M | $362.0M | −$117.8M (−24.6%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Vor Biopharma Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 629,342 | $7.31M | 2.09% |
| OUP Management Co., LLC | 374,714 | $4.35M | 1.96% |
| Ameriprise Financial Inc | 57,683 | $670.0K | 0.00% |
| Ensign Peak Advisors, Inc | 40,426 | $470.0K | 0.00% |
| Citadel Advisors LLC | 24,897 | $289.0K | 0.00% |
| HRT Financial LP | 21,233 | $246.0K | 0.00% |
| Goldman Sachs Group Inc | 17,237 | $200.0K | 0.00% |
| Susquehanna International Group, LLP | 12,360 | $144.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 10,149 | $118.0K | 0.00% |
| Eagle Bay Advisors LLC | 150 | $2.00K | 0.00% |
| Daiwa Securities Group Inc. | 109 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Vor Biopharma Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Putnam Investments LLC | 238,438 | $3.74M |
| SG Americas Securities, LLC | 10,868 | $170.0K |
| The PNC Financial Services Group, Inc. | 2,000 | $31.0K |
| Captrust Financial Advisors | 37 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Vor Biopharma Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Trustees of Columbia University in the City of New York | 91,910 | $1.44M |